38 Heart rate variability and pre-hospital risk stratification of chest pain patients. (16th April 2018)

• Record Type: Journal Article
• Authors: Ting, Chu En; Liu, Nan; Koh, Zhi Xiong; Guo, Dagang; Ji NG, Janson Cheng; Lim, Swee Han; Hock Ong, Marcus Eng
• Is Part Of: BMJ open. Volume 8:Supplement 1(2018)
• Page Start: A14
• Page End: A14
• Publication Date: 2018-04-16
• Subjects: Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2018-EMS.38
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Aim: Assessment of chest pain patients often requires extensive investigations, while existing risk-scores are designed for use in Emergency Departments (ED). We aim to develop a risk score for chest pain patients in pre-hospital settings and ambulances by utilising heart rate variability (HRV), a rapid, non-invasive reflection of cardiac stress states. Method: This study analysed 902 chest pain cases presenting to Singapore General Hospital (SGH) ED between 2010 and 2015. The data was divided into a model derivation set (616 cases, 32% meeting outcomes) and a validation set (286 cases, 28.7% meeting outcomes). HRV Prediction Model (HRV-PM) for 30 day Major Adverse Cardiac Events (MACE) was derived using backward-stepwise logistic regression. HEART, TIMI and GRACE scores were used as comparators for the HRV-PM. Results: In the derivation set, 66.9% of patients were male, with a mean (SD) age of 60.71 (12.97). HRV-PM encompasses 9 parameters: 6 HRV variables (triangular interpolation of normal-to-normal intervals, total power, very-low/low/high-frequency power, approximate entropy), and 3 ECG variables (ST-elevation, ST-depression, Q-wave). Validation of HRV-PM shows similar performance to HEART for 30 day MACE prediction with Area Under Receiver-Operating-Curve (AUC) of 0.737 (95% CI: 0.673 to 0.800) versus 0.739 (95% CI: 0.679 to 0.799). The addition of 1 set of troponin results in HRV-PM improves the AUC to 0.749 (95% CI: 0.686 to 0.813), thereby outperforming HEART. Conclusion: HRV-PM is a simple, non-invasive test demonstrating comparable performance with HEART without need of blood-tests. We hope to validate and apply HRV-PM for assessment of chest pain patients by EMS in pre-hospital settings including ambulances. Conflict of interest: None Funding: None